Tuesday, March 25, 2025
55.3 F
New York

Tag: targeted breast cancer therapies

Who Should Get Genetic Testing for Breast Cancer? New Guidelines, Risk Criteria, and What Patients Need to Know

Genetic testing for breast cancer has become one of the most powerful tools in modern oncology. With ongoing advances in genomic research, medical professionals are better equipped to identify individuals at elevated risk, personalize treatment plans, and guide preventive care strategies. Understanding who should get genetic testing for breast cancer is more important than ever, especially as new guidelines broaden eligibility. This article explores the clinical value of genetic testing, recent updates to testing criteria, the role of family history, and how accurate genetic testing is in determining risk.

Breakthrough in Oncology: New Treatments for HER2 Positive Breast Cancer Offer Hope for Triple Positive Patients

In the evolving landscape of oncology, few areas have seen as significant progress in recent years as the treatment of HER2-positive breast cancer. This particularly aggressive form of the disease, characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein, was once associated with poor prognoses and limited therapeutic options. However, ongoing breakthroughs in targeted therapies and personalized medicine are rewriting the narrative for thousands of patients. Among those who stand to benefit the most are individuals diagnosed with triple positive breast cancer—a subtype that also expresses estrogen and progesterone receptors alongside HER2.